One major reason is that GSIs have activity against T-ALL with NOTCH1 mutations but not those with PTEN deficiency and activation of PI3K-AKT signaling [30], as well as constitutive MYC expression [139]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.